RPS2P5

Across TCGA pan-cancer cohorts, RPS2P5 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RPS2P5 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPS2P5 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPS2P5 expression acts as an unfavorable survival marker, although some lineages such as UVM and GBM show a favorable association.

UVM, KIRP, and ACC are the cancer types where RPS2P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.802	0.327	<.001	93	view →
KIRP	DFS	Tertile	All	0.824	0.969	<.001	89	view →
ACC	DFS	Median	All	0.276	0.613	<.001	74	view →
GBM	DFS	Tertile	All	0.356	0.190	.002	32	view →
OV	OS	Tertile	II,III,IV	0.263	0.383	.003	28	view →
LIHC	OS	Median	All	0.725	0.822	.017	25	view →
COAD	DFS	Median	All	0.666	0.323	<.001	24	view →
STAD	DFS	Median	II,III,IV	0.572	0.278	.001	14	view →
MESO	OS	Tertile	IV	0.277	0.818	.006	12	view →
THCA	DFS	Median	IV	0.437	0.865	.001	9	view →
SARC	OS	Tertile	All	0.402	0.570	.005	9	view →
READ	OS	Median	IV	0.466	0.824	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RPS2P5–UVM (OS)

Open the UVM breakdown →